FINANCE
BUSINESS MODEL
B2B - Revenue License model
2024
Protocols set up and pre-clinical Studies (animal)
2025
IND enabling studies in animal models for human trials
2026
Phase 1 clinical trial in human
Expected revenue
License Agreement with a Pharma Company for the Co-development of Phase 2 Clinical Studies in Human